IMDX

Insight Molecular Diagnostics
IMDX

Overview Fund Trends Analyst Outlook Journalist POV

34 hedge funds and large institutions have $5.64M invested in Insight Molecular Diagnostics in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10: →

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

67% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 12

Holders
34
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$356K
2
+$74K
3
+$42K
4
MHP
Manatuck Hill Partners
Connecticut
+$23.8K
5
TRCT
Tower Research Capital (TRC)
New York
+$4.23K

Top Sellers

1
-$238K
2
-$163K
3
-$135K
4
BIT
BlackRock Institutional Trust
California
-$84.3K
5
New York State Common Retirement Fund
New York State Common Retirement Fund
New York
-$63K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$1K
27
$178
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
1
2